Abstract
Purpose: To determine the clinical benefit of high-dose early adjuvant radiotherapy (EART) in high-risk prostate cancer (hrCaP) patients submitted to radical retropubic prostatectomy plus pelvic lymphadenectomy. Patients and Methods: The clinical outcome of 334 hrCaP (pT3-4 and/or positive resection margins) node-negative patients submitted to radical retropubic prostatectomy plus pelvic lymphadenectomy before 2004 was analyzed according to the EART dose delivered to the prostatic bed,
Original language | English |
---|---|
Pages (from-to) | 966-974 |
Number of pages | 9 |
Journal | International Journal of Radiation Oncology Biology Physics |
Volume | 75 |
Issue number | 4 |
DOIs | |
Publication status | Published - Nov 15 2009 |
Keywords
- Adjuvant
- Dose
- Prostatectomy
- Prostatic neoplasms
- Radiotherapy
ASJC Scopus subject areas
- Cancer Research
- Oncology
- Radiology Nuclear Medicine and imaging
- Radiation